BO

BOLAK CO.,LTD

Manufacturer of specialty ingredients for the food, pharmaceutical, and cosmetic industries.

002760 | KO

Overview

Corporate Details

ISIN(s):
KR7002760007
LEI:
Country:
South Korea
Address:
경기도 화성시 양감면 초록로 720-37, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1959, Bolak Co., Ltd. is a manufacturer of specialty ingredients and raw materials. The company serves the food, pharmaceutical, and cosmetic industries with a diverse product portfolio. Key offerings include food additives such as flavors, coloring agents, and gum base, for which it was a domestic pioneer. The company also develops and produces active pharmaceutical ingredients (APIs), with specialized capabilities for high-potency compounds, as well as functional food materials and cosmetic and botanical extracts for a global and domestic customer base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 83.3 KB
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 749.3 KB
2025-08-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.6 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 757.2 KB
2025-04-28 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.6 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 19.2 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 11.5 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 949.2 KB
2025-03-18 00:00
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 20.6 KB
2025-03-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 213.3 KB
2025-03-14 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.3 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 128.2 KB
2025-03-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 12.4 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.1 KB
2024-12-09 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 3.9 KB

Automate Your Workflow. Get a real-time feed of all BOLAK CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BOLAK CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BOLAK CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT

Talk to a Data Expert

Have a question? We'll get back to you promptly.